| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,3 M € | +82.9% | 4,5 M € | +3.5% | 4,4 M € | +41.4% | 3,1 M € | +258.7% | 862,9 k € | +1147.6% | 69,2 k € | — | — | — | — | — | — | — | — | — | — | |||||||||||
| Gross margin | — | — | — | — | — | — | -2,8 M € | +54.8% | -6,3 M € | -27.3% | -5,0 M € | -14.9% | -4,3 M € | -403.5% | -856,1 k € | -110.3% | 8,3 M € | +373.6% | -3,0 M € | -25.7% | -2,4 M € | -225.5% | -744,2 k € | -120.0% | -338,2 k € | |||||||
| EBITDA | -83,2 M € | -41.2% | -58,9 M € | -51.0% | -39,0 M € | -36.2% | -28,6 M € | -15.6% | -24,8 M € | -190.2% | -8,5 M € | -62.1% | -5,3 M € | +37.2% | -8,4 M € | -20.5% | -7,0 M € | +37.4% | -11,1 M € | -420.6% | -2,1 M € | -170.8% | 3,0 M € | +188.7% | -3,4 M € | -36.5% | -2,5 M € | -221.7% | -774,7 k € | -128.2% | -339,5 k € | |
| Operating profit | -88,2 M € | -34.9% | -65,4 M € | -40.4% | -46,6 M € | -43.2% | -32,6 M € | -17.0% | -27,8 M € | -210.0% | -9,0 M € | -69.2% | -5,3 M € | +37.1% | -8,4 M € | -19.7% | -7,0 M € | +36.9% | -11,2 M € | -171.5% | -4,1 M € | -437.7% | -764,2 k € | +77.6% | -3,4 M € | -36.5% | -2,5 M € | -222.0% | -776,5 k € | -128.2% | -340,3 k € | |
| Profit/loss | -90,9 M € | -48.5% | -61,2 M € | -36.7% | -44,8 M € | -51.1% | -29,6 M € | -9.6% | -27,0 M € | -142.9% | -11,1 M € | -66.9% | -6,7 M € | +25.1% | -8,9 M € | -17.6% | -7,6 M € | +32.9% | -11,3 M € | -166.4% | -4,2 M € | -367.2% | -907,3 k € | +74.0% | -3,5 M € | -36.2% | -2,6 M € | -215.1% | -812,3 k € | -129.2% | -354,4 k € | |
| Equity | 51,9 M € | -57.0% | 120,8 M € | +11.3% | 108,6 M € | -19.4% | 134,7 M € | -17.9% | 164,1 M € | +55.1% | 105,8 M € | +1392.1% | 7,1 M € | -48.5% | 13,8 M € | +79.7% | 7,7 M € | -49.7% | 15,2 M € | +39.5% | 10,9 M € | +10.6% | 9,9 M € | +1166.7% | -924,9 k € | -1177.8% | 85,8 k € | +182.0% | -104,6 k € | +64.2% | -292,4 k € | |
| Total assets | 112,0 M € | -26.4% | 152,3 M € | +28.6% | 118,4 M € | -16.7% | 142,2 M € | -16.5% | 170,2 M € | +51.7% | 112,2 M € | +898.1% | 11,2 M € | -32.6% | 16,7 M € | +64.6% | 10,1 M € | -41.4% | 17,3 M € | +50.0% | 11,5 M € | +8.0% | 10,7 M € | +525.9% | 1,7 M € | -12.5% | 2,0 M € | +218.3% | 612,9 k € | +385.1% | 126,3 k € | |
| Cash | 4,7 M € | +177.9% | 1,7 M € | -78.1% | 7,7 M € | -36.8% | 12,3 M € | -90.7% | 131,2 M € | +45.1% | 90,4 M € | +1886.7% | 4,6 M € | -71.2% | 15,8 M € | +64.2% | 9,6 M € | -43.5% | 17,1 M € | +257.9% | 4,8 M € | +9.0% | 4,4 M € | +430.8% | 823,9 k € | +18.2% | 696,8 k € | +17.9% | 590,9 k € | +17295.7% | 3,4 k € | |
| Debts | 56,1 M € | +115.2% | 26,1 M € | +180.4% | 9,3 M € | +29.5% | 7,2 M € | +39.6% | 5,1 M € | -15.9% | 6,1 M € | +53.9% | 4,0 M € | +38.4% | 2,9 M € | +20.4% | 2,4 M € | +20.5% | 2,0 M € | +281.1% | 518,7 k € | +53.1% | 338,9 k € | -83.0% | 2,0 M € | +6.7% | 1,9 M € | +179.4% | 667,7 k € | +59.5% | 418,7 k € | |
| Staff | 43,1 | 47 | 37,7 | 34 | 18,5 | 10,7 | 9,6 | 8,9 | 7,7 | 4,7 | 2,5 | 3 | 2,4 | 0,7 | 0,3 | — | ||||||||||||||||
Public limited company · Mont-Saint-Guibert · incorporated on 15/07/2009 · 43,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+177.9%).
Solid counterparty for a standard engagement.
NYXOAH is a Public limited company incorporated in 2009. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Mont-Saint-Guibert. It employs on average 43,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette